Objectives: To investigate cross-sectional and longitudinal associations between systemic bone mineral density (BMD), subchondral BMD (sBMD) and knee cartilage thickness in older adults with or without radiographic osteoarthritis (ROA).
INTRODUCTION
Osteoarthritis (OA) is a slowly progressive and multifactorial disease characterised by gradual loss of articular cartilage.(1) It has long been hypothesised that systemic or local bone mineral density (BMD) is involved in the pathogenesis of cartilage degradation; (2) (3) (4) however, studies regarding the association between BMD and incidence or progression of OA are still controversial.
While some studies demonstrated that high systemic BMD and BMD gain decreased the risk of progression of knee radiographic OA (ROA) or osteophyte progression, (5, 6) others reported that high BMD in women was associated with incident ROA,(6, 7) or was not related to hip osteophyte formation. (8) A recent study with large sample size documented that higher systemic BMD was associated with a greater risk of incident ROA, but not the progression of existing ROA.(9) Subchondral BMD (sBMD) and subchondral bone remodelling also play important roles in OA pathology. (10, 11) Some studies have demonstrated that knee OA was associated with lowers BMD, (3, 12) while another study documented that patients with high tibial sBMD had increased joint space narrowing (JSN) over 1 year. (13) These inconsistencies may be partly due to the radiographic assessment of OA incidence or progression being insensitive. JSN assessed by radiographs only provides an indirect estimateof cartilage loss and is subject to measurement errors due to change in positioning.
Cartilage thickness assessed from magnetic resonance imaging (MRI) as a potential morphologic biomarker of OA has been recommended by an international panel of experts and has been recognised as an important quantitative measurement of knee osteoarthritic status. (14, 15) While Raynauld et al reported that measurements of both cartilage thickness and cartilage volume provided the same level of sensitivity to estimate cartilage loss in patients with symptomatic OA (16), Reichenbach et al suggested that reduced knee cartilage thickness rather than volume was observed in subjects with mild to moderate ROA compared with those without radiographic OA. (17) Both loss of cartilage volume and loss of cartilage thickness can predict future knee replacement. (17, 18) Although some studies reported that systemic BMD was cross-sectionally associated with increased knee cartilage volume, (19) (20) (21) the associations between systemic and/or subchondral BMD and knee cartilage thickness have not been reported. It is also unclear if systemic BMD and sBMD play different roles in cartilage loss over the process of OA. The aim of this study, therefore, was to determine the cross-sectional and longitudinal associations between systemic BMD, subchondral BMD and knee cartilage thickness in older adults with or without ROA.
MATERIALS AND METHODS

Study design and subjects
This study was conducted as part of the Tasmanian Older Adult Cohort (TASOAC) study, a prospective epidemiological study of 1100 persons aged 50-79 years, with a goal of identifying the environmental, genetic and biochemical factors associated with the development and progression of OA and osteoporosis (the overall response rate was 57%). Participants were selected randomly using computer generated random numbers from the electoral roll in southern Tasmania (population 229,000), a comprehensive population listing, with an equal number of men and women. Institutionalised persons were excluded. The study was approved by the Southern Tasmanian Health and Medical Human Research Ethics Committee, and written informed consent was obtained from all participants. Self-report of smoking status and disease status such as rheumatoid arthritis (RA), asthma, cardiovascular disease and diabetes were recorded by questionnaire as such disease status may be potential confounders for bone or cartilage metabolism. Baseline measurements were carried out from April 2002 to September 2004 with a predefined time point for each participant, and the first follow up was conducted 2.7 years later (range 2.6-3.3 years).. At baseline and 2.7 years' follow up, all participant received MRI and dual energy x-ray absorptiometry (DXA) scan, while the first 158 participants were selected to perform the semi-automated measurements of cartilage thickness.
Anthropometrics
Height was measured to the nearest 0.1 cm by using a stadiometer with shoes, socks and headgear removed. Weight was measured to the nearest 0.1 kg (with shoes, socks and bulky clothing removed) using a single pair of electronic scales (Seca Delta Model 707, Bradford, Massachusetts, USA) that were calibrated using a known weight at the beginning of each clinic.
Body mass index (BMI) [weight (kg)/height 2 (m 2 )] was calculated.
BMD measurement
Bone mass was measured using a Hologic DXA scanner (Hologic Corp., Waltham, Massachusetts, USA). Bone mass was examined as areal BMD (g/cm 2 ), which is calculated by dividing the bone mineral content (BMC) by the area measured and was measured at total hip, lumbar spine and total body at baseline. The precision estimate in vivo is 2% in our hands. (22) By using existing spine software, medial and lateral sBMD of the tibia were measured in regions of interest (ROIs) including the subchondral plate and had a height of 10 mm.
Reproducibility and validity in these ROIs have been demonstrated in our previous study.(23,
24)
Knee cartilage thickness measurement for non-contiguous portions of cartilage to be grouped together, and was sensitive to portions of cartilage unconnected in the same slice.
For our analysis, femoral cartilage was considered as a single region, as was patellar cartilage.
Medial and lateral tibial portions of cartilage were considered as separate whole regions.
Analysis was also performed using all knee cartilage combined. Mean thickness for a region of cartilage was calculated as the mean distance from inner to outer surface, from a sample of uniformly spaced points over the entire cartilage-covered surface. Intra-observer reproducibility (measured in 20 subjects) for mean cartilage thickness, as measured by coefficient of variation (CV), was 1.9-2.9%. This is similar to that for cartilage volume in our hands. (27) Knee cartilage volume and bone marrow lesion measurements
Knee cartilage volume and bone marrow lesions (BMLs) were determined by means of image processing on an independent work station as previously described. Interactions between ROA (or sex) and BMD were investigated by testing the statistical significance of the coefficient of a product term (ROA or sex × BMD) after adjustment for confounders. A p value <0.05 (two-tailed) or a 95% confidence interval not including the null point (for linear regression) was regarded as statistically significant. All statistical analyses were performed on SPSS V20.0 for Windows (SPSS, Chicago, Illinois, USA).
RESULTS
There were no significant differences in demographic factors between the current cohort and the subjects who did not have cartilage thickness measured (data not shown). Of 158 subjects (48.1% female) included in the analysis, the average age at baseline was 62.6 years, and the mean BMI was 27.4kg/m 2 . Subjects with (n=89) or without ROA (n=69) were similar in terms of age, gender, BMI, BMD, sBMD at medial tibial site, BMLs, smoking and disease status; however, subjects with ROA had reduced sBMD at lateral tibial site (p=0.05) and a lower cartilage thickness (P<0.05) except in whole femur site (Table 1) . Tibial sBMD was not measured in 19 subjects (4 without ROA, 15 with ROA) at baseline because the tibial DXA films could not be found. There were significant interactions between ROA status and BMD on baseline cartilage or change in cartilage thickness, so subjects with ROA and non-ROA were separated for analyses. There were no significant interactions between sex and BMD on baseline cartilage thickness or change in cartilage thickness, so males and females were combined for analyses.
In cross-sectional analyses of ROA subjects, total body and spine BMD were significantly associated with knee cartilage thickness at whole femoral, whole patellar and lateral tibial sites before and after adjustment for age, sex, BMI, disease status and knee radiographic features (Table 2) . Total hip BMD was also significantly associated with femoral, patellar and lateral tibial cartilage thickness in univariable analysis and remained significant at femoral and lateral tibial sites after adjustment for the covariates as mentioned above (Table 2) . After further adjustment for medial and/or lateral tibial sBMD, the significant associations decreased in magnitude and became non-significant except those at lateral tibial site ( Table 2 ).
As shown in Table 3 , we did not find significant associations between medial sBMD and knee cartilage thickness at any site, but lateral sBMD was significantly associated with femoral and patellar cartilage thickness in multivariable analyses. After further adjustment for total body BMD, the association with femoral cartilage thickness remained significant but decreased in magnitude, and the association with patellar cartilage thickness became non-significant (Table   3) .
Longitudinally, in subjects with ROA, a high baseline spine BMD was associated with an increase in cartilage thickness in both femoral and lateral tibial sites, and baseline total body BMD was positively associated with change in whole femoral cartilage thickness, after adjustment for age, sex, BMI, baseline cartilage thickness, radiographic features and disease status (Table 4) . Baseline medial sBMD was also positively associated with change in cartilage thickness in medial tibial site before and after the adjustment in ROA subjects (Table 5 ). All these significant values in longitudinal data were largely unchanged after further adjustment for sBMD if systemic BMD or total body BMD if sBMD (Table 4 , 5).
In non-ROA subjects, before and after adjusting for above confounders, we did not find any 
DISCUSSION
This is, to the best of our knowledge, the first study to examine the relationship between knee cartilage thickness and systemic or local BMD. In this prospective cohort of older adults, we documented that in subjects with ROA, total body and spine BMD were significantly associated with knee cartilage thickness at whole femoral, whole patellar and lateral tibial sites cross-sectionally; and longitudinally, they were also positively associated with increases in whole femoral or lateral tibial cartilage thickness over 2.7 years. Consistent with systemic BMD, medial tibial sBMD predicted increased medial tibial cartilage thickness. These suggest a causal relationship between low BMD and loss of cartilage thickness in ROA. We did not find significant associations between BMD and cartilage thickness in subjects without ROA.
It has been a commonly-held belief that OA is more common in subjects with high BMD; (31, 32) however, the role of BMD in progression of ROA is still uncertain. Some studies have documented that higher BMD protects against ROA or JSN progression (5, 6); on the contrary, There are a number of potential limitations in this study. First, the response rate at baseline was 57%, possibly due to the demands on study participants in that each visit took 3 hours. This did
leave the possibility open for selection bias. However, there were no significant differences in age and gender between those responded and those did not. We also had high rates of retention (82%) to offset this. Second, the sample size was modest. It is possible that with a larger sample we may have been able to detect more significant associations. Third, although we studied a well-characterised population of older adults with a high level of knee pain (46%), this randomly selected sample unavoidably included subjects with other diseases, which may have affected the associations. Nevertheless, the results were largely unchanged when the analyses were adjusted for disease status or the subjects with other diseases were excluded. Fourth, disease status was not confirmed by medical records in this study; however, the results remained largely unchanged before and after adjustment for disease status, suggesting it was not a critical confounder. Last, measurement error may influence results. However, given all measures (e.g., cartilage thicknessand BMD) were highly reproducible, this is considered unlikely.
In summary, while total body, total hip and/or spine BMD is positively associated with increased cartilage thickness cross-sectionally and longitudinally in subjects with ROA, a high medial tibial sBMD predicts an increase in medial tibial cartilage thickness. These suggest that both systemic and subchondral BMD play a protective role against cartilage loss in knee OA. 
